Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Allergy & Immunology
•
Asthma
Do you utilize urinary leukotrienes as a marker for initiation of montelukast?
Answer from: at Academic Institution
No, I don’t. It is not readily available clinically and has not been shown to be predictive of response.
Sign In
or
Register
to read more
23597
Related Questions
Would you stop Dupixent in an asthma patient who has good asthma control and notes improvement in loss of smell, but shows notable eosinophil elevation after 4-5 doses of the medication?
In a patient with selective IgM deficiency who is completely asymptomatic in terms of infections, what is your typical laboratory work up?
Do you withhold performing skin testing for aeroallergens, foods or venoms based on poor lung function?
What is your approach to distinguishing a Jarisch-Herxheimer reaction from a delayed anaphylactoid reaction?
In light of recent measles outbreaks in the US, would you recommend an MMR booster for immunocompetent patients born before 1957?
Which biologics for asthma have data regarding mucus plugging?
Do you generally favor nebulizers, HFAs or other devices in children aged 5 and younger with asthma?
Do you plan to use benralizumab to treat acute exacerbations of asthma or COPD associated with eosinophilia?
Should a patient on medium-dose ICS/LABA with normal PFTs, but who shows a greater than 10% decrease in FEV1 if their PFTs are done after 24 hours off their inhaler, be started on a biologic?
Is there a specific group of children that you start on AIT for prevention of asthma?